IntegerBio


IntegerBio is at the forefront of Immunovirology, committed to combating serious viral diseases by pioneering the intersection of immunology and virology. The company focuses on developing broad multi-viral therapeutics using cutting-edge biology and data-focused approaches. Their mission is to harness the power of science to design therapeutics with durable responses across multiple viruses, aiming for a future without the fear of viral disease.

IB_LOGO_H_RBG

IntegerBio

704 Quince Orchard Road Suite 120 Gaithersburg, MD 20878


What We Do

SYNFERON™ molecules are synthetic proteins designed to target Interferon-alpha receptors, IFNAR1 and IFNAR2, to synergize pathways of the immune system. They are developed to program the Type I Interferon pathway for potent multi-viral activity while minimizing inflammation and reducing side effects.


Infectious Diseases


Key People

Chief Executive Officer

LinkedIn

Chief Scientific Officer

LinkedIn

Chief Operating Officer

LinkedIn

Chief People Officer

LinkedIn

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.